Takeda Pharmaceutical Co. Ltd. - Interest Income

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Interest-Income" stands at 133.31 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2023.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 44.40 Billion JPY for the item "Interest Income" represents a decrease of -39.81 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 44.40 Billion JPY for the item "Interest Income" represents an increase of 978.62 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 133.31 Billion JPY for the item "Interest Income" represents an increase of 43.30 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 45.87 percent compared to the value the year prior.
The 1 year change in percent is 45.87.
The 3 year change in percent is 34.77.
The 5 year change in percent is 56.58.

The Serie's long term average value is 82.61 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 61.38 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is +4,630.62%.
The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -2.43%.